Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New antiarrhythmic agents in pediatrics.

C L Case1, D L Trippel, P C Gillette

  • 1South Carolina Children's Heart Center, Charleston.

Pediatric Clinics of North America
|October 1, 1989
PubMed
Summary

This review covers new pharmacologic treatments for pediatric arrhythmias, focusing on six novel antiarrhythmic agents. Pediatricians will increasingly manage children using these medications due to rising diagnoses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of feeding organic and inorganic sources of additional zinc on growth performance and zinc balance in nursery pigs.

Journal of animal science·2002
Same author

Atrioventricular block in a newborn with acquired long QT syndrome.

Cardiology in the young·2002
Same author

Using 12-lead ECG and synthesized VCG in detection of right ventricular hypertrophy with terminal right conduction delay versus partial right bundle branch block in the pediatric population.

Journal of electrocardiology·2002
Same author

Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study.

Lancet (London, England)·2000
Same author

Diagnosis and treatment of pediatric arrhythmias.

Pediatric clinics of North America·1999
Same author

QT dispersion in children with ventricular arrhythmia and a structurally normal heart.

Pacing and clinical electrophysiology : PACE·1999

Area of Science:

  • Pediatric Cardiology
  • Pharmacology
  • Electrophysiology

Background:

  • Arrhythmias in children are increasingly recognized and complex.
  • Pediatricians face a growing need for effective antiarrhythmic treatments.
  • Advances in antiarrhythmic pharmacology are crucial for managing pediatric rhythm disturbances.

Purpose of the Study:

  • To review recent advancements in the pharmacologic management of pediatric arrhythmias.
  • To provide detailed information on six newer antiarrhythmic agents.
  • To equip pediatricians with knowledge on current and emerging treatments for childhood arrhythmias.

Main Methods:

  • Literature review of recent developments in pediatric arrhythmia management.
  • Focused analysis of six specific newer antiarrhythmic medications.
  • Synthesis of clinical information relevant to pediatric practice.

Main Results:

  • Identified and detailed six novel antiarrhythmic agents for pediatric use.
  • Highlighted the increasing frequency and complexity of arrhythmias in children.
  • Emphasized the growing need for pediatricians to be familiar with these medications.

Conclusions:

  • Newer antiarrhythmic agents offer expanded options for managing pediatric arrhythmias.
  • Increased recognition of pediatric arrhythmias necessitates updated clinical knowledge.
  • Pediatricians must stay informed about emerging pharmacologic strategies for rhythm control in children.

Related Experiment Videos